knowledge -WSS

knowledge

author：leisure time 2025-10-01 01:49:44 - browse：5

Adobe

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million.

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued the company at about $1 billion. But despite several strategic pivots, including shifting to direct-to-consumer sales, the company failed to build a sustainable business model. Akili in April announced it would wind down its existing commercial operations and focus on a licensing deal with Japanese pharma company Shionogi while it figured out the best path forward.

Akili is just one of many health tech companies that are struggling following an explosion of investor interest in digital health during the Covid-19 pandemic. In the last month alone, Better Therapeutics, another company making digital treatments, sold its assets for an undisclosed amount after failing to build a business around its app for type 2 diabetes, and Cue Health, a diagnostics startup, shut down after funding interest in its Covid-19 tests evaporated.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： An interview with Robert F. Kennedy Jr. on vaccines

leisure time

WSS

ActiGraph execs on goal of drug approvals with digital endpoints

Congress: Prevent baby formula shortages by passing a new bill

The Bio Revolution is changing business and society

Evacuations in place as 3 wildfires burn in eastern Washington state

An interview with Robert F. Kennedy Jr. on vaccines

New definition of a human embryo proposed amid rapid advances

knowledge

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

The high cost of giving birth even with insurance

Why we need mandatory labeling of GMO products

Wildfire smoke exposes gaps in outdoor worker protections

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Dobbs anniversary: the lost opportunity of abortion as health care

J&J reports mixed data on next

Supreme Court strikes down use of affirmative action

Clinicians often fail to acknowledge the pain caused by long Covid

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Wikipedia

J&J reports mixed data on next

Lawsuit challenges CMS nursing home minimum staffing rule

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Stroke rates rising, especially in working

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Why some fertility treatments produce more boy babies

leisure time

leisure time

hotspot

leisure time